
Regulatory
- Research & Development (R & D)
- Clinical Research
- SAS (Statistical Analysis System)
- Dossiers
- Pharmacovigilance
our documentation






about us
Setting new standards in pharmaceutical documentation excellence,

We strive to deliver the best pharmaceutical documentation experience for you.

We are committed to delivering the highest standard of pharmaceutical documentation.
Pharmacist have main role in pharmaceuticals sector
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
sales associate

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
retail specialist

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
studio executive

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
Business Analyst

news & blogs
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin nisi elit, consequat pharetra elementum nec, eleifend non turpis.
Learn nitrosamine testing in pharmaceuticals, regulatory requirements, LC-MS/MS methods, NDSRIs, FDA, EMA, USP <1469>, and GMP compliance. Definition Nitrosamine testing in pharmaceuticals is the analytical process used to detect, identify, and quantify potentially carcinogenic nitrosamine impurities such as NDMA, NDEA, NMBA, and NDSRIs at trace levels, typically in the parts-per-billion (ppb) range. Pharmaceutical manufacturers use…
Learn extractables and leachables testing for pharmaceutical packaging, USP <1663>/<1664>, risk assessment, analytical methods, and GMP compliance. Definition Extractables and Leachables (E&L) testing is a scientific evaluation used to identify, quantify, and assess chemicals that can migrate from pharmaceutical packaging, container closure systems, manufacturing equipment, and delivery devices into drug products. The testing ensures product…
Learn the root causes of dissolution testing failures, investigation techniques, CAPA strategies, FDA expectations, and GMP best practices. Definition What is a dissolution testing failure? A dissolution testing failure occurs when a pharmaceutical product does not meet its approved dissolution specification during release, stability, validation, or investigation testing. Such failures may result from formulation issues,…
Compare TOC, HPLC, and swab testing for cleaning validation. Learn regulatory requirements, MAC calculations, method validation, and GMP best practices. Definition Cleaning validation analytical methods are laboratory techniques used to detect and quantify product, excipient, and cleaning agent residues remaining on pharmaceutical equipment after cleaning. The most commonly used methods are HPLC (specific residue analysis),…
Learn ICH Q3D and ICH Q3C compliance requirements, risk assessments, PDE calculations, testing strategies, GMP expectations, and regulatory best practices. Definition ICH Q3C and ICH Q3D are international pharmaceutical guidelines that establish risk-based limits for residual solvents and elemental impurities in drug products. They require manufacturers to perform toxicological risk assessments, establish Permitted Daily Exposure…
Learn DQ, IQ, OQ, and PQ for analytical instrument qualification with GMP requirements, USP <1058>, examples, and audit-ready practices. Definition Analytical Instrument Qualification (AIQ) is the documented process of demonstrating that laboratory equipment is properly designed, installed, operates as intended, and consistently performs according to predetermined specifications. The qualification lifecycle includes Design Qualification (DQ), Installation…
FAQ’s
Pharma Documentation Simplified.
Pharmaceutical documentation is the systematic recording of processes, procedures, tests, and controls involved in the manufacturing, quality assurance, and distribution of pharmaceutical products. It ensures product quality, safety, traceability, and regulatory compliance.
Documentation is critical to ensure:
• Compliance with regulatory requirements (GMP, DRAP, FDA, WHO, USP, BP)
• Product quality and patient safety
• Traceability and accountability
• Data integrity and audit readines
Common pharmaceutical documents include:
• Standard Operating Procedures (SOPs)
• Batch Manufacturing Records (BMR)
• Batch Packaging Records (BPR)
• Master Formula Records (MFR)
• Validation protocols and reports
• Quality control and stability reports
• Change control and deviation records
Good Documentation Practices (GDP) are guidelines that ensure documents are:
GDP helps maintain data integrity and regulatory compliance.
Accurate, clear, and legible
Written in real time
Properly signed and dated
Secure and traceable
All personnel involved in pharmaceutical operations share responsibility for accurate documentation. However, Quality Assurance (QA) is primarily responsible for document approval, control, revision, and archiving.
Common errors include:
* Incomplete or inconsistent records
* Missing signatures or dates
* Overwriting or use of correction fluid
* Backdating entries
* Illegible handwriting
Pharmaceutical documentation is governed by:
* USP, BP, and IP standards
* WHO-GMP guidelines
* FDA 21 CFR Parts 210, 211, and 11
* MHRA Act & Rules
* ICH guidelines
Documentation quality can be improved by:
* Regular staff training
* Standardized templates
* Routine audits and reviews
* Clear SOPs and GDP enforcement
* Use of digital documentation systems